Keynote Plenary Speakers

André Kuipers (Rotterdam, Netherlands)

Doctor and astronaut, André Kuipers is the first Dutchman with two space missions to his name. His second mission is the longest spaceflight in European history. In total the ESA astronaut spent 204 days in space: 11 days during mission DELTA in 2004 and 193 days during mission PromISSe. After years of training in Houston, Moscow, Cologne, Montreal and Tokyo, a Russian Soyuz spaceship launched André and his two crew members from Russia and America on the 21st of December 2011 from Kazakhstan. Two days later he arrived at the International Space Station to live and work for six months. On board he was not only a medical doctor, scientist and flight engineer, but also handyman and ambassador for several charities. On the 1st of July 2012, André returned to Earth and landed in his space capsule in the Kazakh steppe. Astronaut André Kuipers offers a unique look behind the scenes of international human spaceflight. He shares his story about the training, the mission and his exceptional view of our planet.

Antonio Costanzo (Rome, Italy)

Prof. Costanzo gained his MD degree in 1994 and specialised in internal medicine and dermatology. During his career he has included two visiting scientist experiences to the US (UCSD and NIH). He has been involved in translational research on skin cancer and genetic skin diseases since 1997 and has contributed to the characterisation of the role of p53 family members p73 and p63 in response to DNA damage and carcinogenesis. As a parallel project, Prof. Costanzo’s group was also involved in the study of psoriasis pathogenesis. From 2001 to 2012 he worked as Assistant Professor of dermatology at Department of Dermatology, University of Rome, Tor Vergata. In December 2012 he was appointed as Director of the Dermatology Department at Sapienza University of Rome (St Andrew University Hospital) where he also directs the Skin Biology Laboratory.

Richard Langley (Halifax, Canada)

Professor Richard Langley, MD, FRCPC, is a professor and director of research in the Division of Dermatology, Department of Medicine, Dalhousie University, Canada, and was President of the Canadian Dermatology Association (2013-2014). Professor Langley received his BA(Honors) at Queens University, Kingston, Ontario, his undergraduate medical degree at Dalhousie University, his internship in internal medicine, and his fellowship in dermatologic surgery at the University of Toronto, Canada, and completed his fellowship training at Massachusetts General Hospital, Harvard Medical School, USA. Following his training, Professor Langley joined the Faculty of Medicine at Harvard Medical School, and he was the director of the Clinical Investigations Unit at Massachusetts General Hospital until June 2000. Professor Langley has authored over 200 articles, book chapters, and other publications and is a regular reviewer for several medical and dermatology journals. He is a principal investigator and has conducted over 150 Phase 1–3 studies involving most of the biologic agents in psoriasis and new immunotherapies in atopic dermatitis. He also conducted the initial work and helped pioneer the application of diagnostic in vivoconfocal microscopy in benign and malignant melanocytic lesions. Professor Langley has been the recipient of numerous awards for teaching, research, clinical practice, and volunteer activities.

Marcel Jonkman (Groningen, Netherlands)

Marcel Jonkman is 56 years old and currently professor and chair of the Department of Dermatology at the University Medical Centre Groningen in the Netherlands. His medical career started in 1984 receiving an MD at the University of Groningen. In 1989 he finished his Ph.D. thesis on artificial skin and epidermal wound healing. After training as a dermato-venereologist he started as assistant professor in 1993 in Groningen with a special interest in bullous diseases. In 1996 he took a fellowship in the lab of Dr. J. Uitto at Jefferson University in Philadelphia, where he discovered the mechanism of revertant mosaicism in skin disease. For the case report on which this discovery was based he received the best poster prize in 1995 at the EADV in Brussels. When he was promoted to associate professor in 1997 he founded the Centre for Blistering Diseases in Groningen. In 2002 Jonkman was appointed as full Professor of Dermatology with special regard to bullous diseases. In 2003 he became chair of the Department of Dermatology in Groningen, and worked between 2004-2012 also as Regional Programme Director for the residents. In the last six years he has modernised the national dermatological resident education programme in the Netherlands. His special interest has always been science. He was founder of the Dutch Society of Experimental Dermatology in 1999. His publication list comprises more than 220 papers in peer-reviewed journals. At the University Medical Centre Groningen he runs the expertise centres for autoimmune bullous diseases and epidermolysis bullosa.

Thomas Bosch (Kiel, Germany)

Thomas Bosch studied biology at the University of Munich, Germany, and Swansea University, United Kingdom, from 1976 to 1983. He earned his doctorate from the University of Munich in 1986. From 1986 to 1988, Bosch held a postdoctoral position at the University of California, Irvine. After holding a position as research associate at the University of Munich, he was appointed to a professorship for zoology at the Friedrich Schiller University of Jena in 1997. Since 2000, Bosch has been a professor of general zoology at University of Kiel. From 2010 to 2013, he served as vice president of University of Kiel and was responsible for its institutional strategy and international relations. Since November 2013, Bosch is heading the interdisciplinary research centre, Kiel Life Science, at the University of Kiel. Bosch is the managing editor of Zoology. He is currently the vice president of the German Society for Developmental Biology and a member of several national and international academic committees and boards. Bosch is the recipient of numerous awards, and in 2014, he received an honorary doctorate degree from St. Petersburg State University, Russia.

Irene Leigh (London, United Kingdom)

Following appointment as Consultant Dermatologist at the Royal London Hospital in 1983 Professor Leigh established the Centre for Cutaneous Research at Barts and The London School of Medicine and Dentistry, Queen Mary University of London (BLSMD) which developed into a premier research centre in skin biology and skin disease in the UK. During this period she became Professor of Dermatology (1992), Professor of Cell and Molecular Medicine (1999), Research Dean (1997-2002), Joint Research Director (2002-5), and Dean for e-learning (2005-6). She was appointed Head of College and Vice Principal of Dundee University in November 2006 and re-established a research laboratory in Dundee including the CR-UK Skin Tumour Laboratory. She was President of the Association of Physicians of UK and Ireland in 2010-11 and a council member of the Academy Medical Sciences 2009-12. She organised IID2013 in Edinburgh. She returned to full time research between Dundee, with programme grants from erc and CR-UK, and Lyon in Global Health with i-pri. She serves on multiple grant giving bodies including the erc. She was honoured with an OBE for services to medicine in 2006 and a CBE in 2012 and was awarded the Archibald Gray medal of the British Association of Dermatologists (BAD) in 2012 and is currently their Academic Vice President. She is a co-PI on a Wellcome Trust Strategic award for Dermatology and Genetic Medicine (DGEM) with Irwin McLean (2012-17) and is the Director of the Clinical network of DGEM: BADGEM in partnership with the BAD.

Tamar Nijsten (Rotterdam, Netherlands)

Tamar Nijsten did his medical and dermatology training in Antwerp (Belgium). Supported by a Fulbright scholarship he started his PhD at Harvard Medical School. In 2005, he started the dermato-epidemiology research group at the Erasmus MC, Rotterdam, the Netherlands and joined its faculty. The focus of his clinical and epidemiological research group is on skin cancer, psoriasis and phlebology and has close ties to public health. In 2010, Tamar Nijsten received the prestigious Vidi-grant to explore the genetics of basal cell carcinoma and was appointed full professor. In addition to his research, he sees patients and supervises residents at the Erasmus MC. He is active in numerous international dermatological organisations including the EADV and EDEN and is section editor for the JID. Currently Tamar Nijsten is chair of the Dutch Society of Dermatology and Venereology. Recently, he was appointed Honorary Professor at Nottingham University (UK) and became chair of the department of dermatology of Erasmus MC, Rotterdam, the Netherlands.